Navigation Links
Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
Date:1/25/2011

REDWOOD CITY, Calif., Jan. 25, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced the company's first biocatalysis collaboration in Japan, with Dainippon Sumitomo Pharma Co., Ltd. (DSP), one of the ten largest Japanese pharmaceutical manufacturers.

Under the agreement, Codexis will supply biocatalysis screening products and services to DSP for use in selected undisclosed therapeutic products in its development pipeline.  Codexis technology is used by innovator pharmaceutical companies worldwide to reduce cost, increase manufacturing efficiency and reduce environmental impact.  

"We are very pleased to be entering the Japanese market through this important collaboration with DSP," said Joseph Sarret, M.D., President, Codexis Pharmaceutical Services and Enzyme Products.  "DSP has identified Codexis technology as a key component in its drive to develop green, sustainable manufacturing processes to serve their key markets, and we look forward to a productive partnership."

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell. Other potential markets include carbon capture, water treatment and chemicals. For more information, see www.codexis.com.  

Dainippon Sumitomo Pharma Co., Ltd. is a multibillion dollar, top ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP aims to produce innovative pharmaceutical products in the CNS field, which has been designated as the key therapeutic area, and the specialty area, designated as a frontier therapeutic area. DSP has more than 7,000 employees worldwide. Additional information about DSP is available through its corporate website at www.ds-pharma.com.

Codexis Forward-Looking Statements

This press release contains forward-looking statements relating to Codexis' collaboration with Dainippon Sumitomo Pharma. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results. Factors that could materially affect actual results can be found in Codexis Quarterly Report on Form 10-Q dated November 4, 2010 including under the caption "Risk Factors." Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Contacts: 

Media: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771. Investors:  Robert Lawson, robert.lawson@codexis.com, 650-421-8137.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
2. Codexis to Present at Piper Conference
3. Codexis to Announce Third Quarter 2010 Financial Results October 28, 2010
4. Codexis Expands Codex® Panel Product Family at CPhI
5. Codexis to Present at the Pacific Crest Technology Leadership Forum
6. Codexis Names Peter Strumph SVP, Commercial Operations
7. Codexis CEO Alan Shaw Named Ernst & Young Entrepreneur Of The Year® 2010 Recipient in Northern California
8. Codexis, Inc. Announces Pricing of Initial Public Offering
9. Codexis Expands Pharmaceutical Manufacturing Partnerships
10. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
11. Codexis Expands Collaboration with Teva
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 2017 Dealmed Medical Supplies, New ... equipment, supplies, drugs, vaccines, and specialty medical products and ... agreement to acquire Vantage Medical Supplies, a major distributor ... Holtsville, New York . ... emerging medical practices, will operate under the Dealmed name ...
(Date:9/7/2017)... Sept. 7, 2017  For nearly two decades, New Life Agency has ... Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way partnership ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... 7, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Morgan ... the Grand Hyatt hotel in New York.  Zimmer Biomet ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .   ...
Breaking Medicine Technology:
(Date:9/21/2017)... FL (PRWEB) , ... September 21, 2017 , ... 38-Year-Old ... Aesthetic Surgery Center in Naples, Florida is pleased to announce that Plastic Surgeon Kiranjeet ... Top 40 Under 40 is an annual award that was started in ...
(Date:9/21/2017)... Chicago, IL (PRWEB) , ... September 21, 2017 , ... ... set to run from September 11 to the end of November. , The Chicago, ... out to their community and teach them about the ease of taking their personal ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and ... departments have been awarded five-year accreditation status through the Public Health Accreditation ... served by a PHAB-accredited health department now extend to more than 203 ...
(Date:9/21/2017)... ... 21, 2017 , ... In addition to sticking with the ... holistic approach and use natural alternatives for all house cleaning products, disinfectants, respiratory ... guaranteeing that, the new line of essential oils, are all 100% organic and ...
Breaking Medicine News(10 mins):